Evidence map›Paper›PMID 38003691›Full record

ReviewInternational journal of molecular sciences2023

Antioxidant and Hypoglycemic Potential of Essential Oils in Diabetes Mellitus and Its Complications.

Simona Gabriela Bungau, Cosmin Mihai Vesa, Cristian Bustea, Anamaria Lavinia Purza, Delia Mirela Tit, Mihaela Cristina Brisc, Andrei-Flavius Radu

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  10. Article
  11. Article
  12. Efficacy of Ma'aljobon Aftimouni (Contemporary clinical trials communications · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Advances in essential oils for metabolic diseases.Frontiers in endocrinology · 2025
    Review
  17. Article
  18. Review
  19. Exploring the Potential ofMolecules (Basel, Switzerland) · 2024
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Simona Gabriela BungauDoctoral School of Biomedical Sciences, University of Oradea, 410087 Oradea, Romania.ORCID 0000-0003-3236-1292
Cosmin Mihai VesaDoctoral School of Biomedical Sciences, University of Oradea, 410087 Oradea, Romania.ORCID 0000-0001-5071-9601
Cristian BusteaDepartment of Surgery, Oradea County Emergency Clinical Hospital, 410169 Oradea, Romania.
Anamaria Lavinia PurzaDepartment of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania.ORCID 0000-0002-2318-9235
Delia Mirela TitDoctoral School of Biomedical Sciences, University of Oradea, 410087 Oradea, Romania.ORCID 0000-0002-0296-6592
Mihaela Cristina BriscDepartment of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.ORCID 0000-0003-3603-8070
Andrei-Flavius RaduDoctoral School of Biomedical Sciences, University of Oradea, 410087 Oradea, Romania.ORCID 0000-0002-7625-8177
University of Oradea · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the earliest times, essential oils (EOs) have been utilized for medicinal and traditional purposes. However, in recent decades, an increasing interest has developed due to the need to rediscover herbal remedies and adjuvant therapies for the management of various diseases, particularly chronic ones. The present narrative review examines the potential for EOs to exert hypoglycemic and antioxidant effects in diabetes mellitus, analyzing the main publications having evaluated plant species with potentially beneficial effects through their phytocompounds in diabetes mellitus and its complications. Numerous species have shown promising characteristics that can be used in diabetes management. The hypoglycemic effects of these EOs are attributed to their capacity to stimulate glucose uptake, suppress glucose production, and increase insulin sensitivity. Moreover, EOs can alleviate the oxidative stress by manifesting their antioxidant effects via a variety of mechanisms, including the scavenging of free radicals, the regulation of antioxidant enzymes, and the decreasing of lipid peroxidation, due to their diverse chemical composition. These findings demonstrate the possible benefits of EOs as adjuvant therapeutic agents in the management of diabetes and its complications. The use of EOs in the treatment of diabetes shows good potential for the development of natural and effective strategies to enhance the health outcomes of people with this chronic condition, but additional experimental endorsements are required.

Indexed as

Diabetes Mellitus, ExperimentalOils, VolatileAnimalsAntioxidantsHumansHypoglycemic AgentsOxidative StressAntioxidantsHypoglycemic AgentsOils, Volatileantioxidantsbibliometric analysisdiabetes mellitusessential oilphytochemistry

Identifiers

PMID38003691
PMCPMC10671358
OpenAlexW4388832062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.